Metraipolis › archive › dc_cdb38fe11459
Sulfasalazine — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Sulfasalazine
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-07T18:47:15.016Z
- SHA-256 of the archived text
fc058fa74d4bc1649e00f9fff8ff23c383225c40a9da079bad47caa7bcfac329- Stable URL of this page
https://metraipolis.com/documento/dc_cdb38fe11459
How to cite
Sulfasalazine — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Sulfasalazine (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_cdb38fe11459 (Metraipolis archive dc_cdb38fe11459, sha256 fc058fa74d4bc1649e00f9fff8ff23c383225c40a9da079bad47caa7bcfac329)
BibTeX
@misc{dccdb38fe11459,
title = {Sulfasalazine — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Sulfasalazine},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_cdb38fe11459; sha256 fc058fa74d4bc1649e00f9fff8ff23c383225c40a9da079bad47caa7bcfac329},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Sulfasalazine. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Sulfasalazine, sold under the brand name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth or can be administered rectally. Significant side effects occur in about 25% of people. Commonly these include loss of appetite, nausea, headache, and rash. Severe side effects include bone marrow suppression, liver problems, Stevens–Johnson syndrome, and kidney problems. It should not be used in people allergic to aspirin or sulfonamide. Use during pregnancy appears to be safe for the baby. Sulfasalazine is in the disease-modifying antirheumatic drugs (DMARDs) family of medications. It is unclear exactly how it works. One proposed mechanism is the inhibition of prostaglandins, resulting in local anti-inflammatory effects in the colon. The medication is broken down by intestinal bacteria into sulfapyridine and 5-aminosalicylic acid. Sulfasalazine was approved for medical use in the United States in 1950. It is on the World Health Organization's List of Essential Medicines. Sulfasalazine is available as a generic medication. In 2020, it was the 284th most commonly prescribed medication in the United States, with more than 1 million prescriptions. Tema degli esploratori: scienze della vita e salute (deposito sistematico; ricerca «pharmacology»). Fonte: Wikipedia in inglese, voce «Sulfasalazine» — https://en.wikipedia.org/wiki/Sulfasalazine Wikidata Q420035: «farmaco» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q420035 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Sulfasalazine?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1314714428, consultata il 2026-11-07T18:42:14.105Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 439c33718d006840859f7e2e90d5d813b5c365d3bece81c16ed6bf65d47223b0